Stockhub

IX Biopharma Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 August 2022

  • curprev 07:2807:28, 23 August 2022 >Nick 1,453 bytes +1,453 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == iX Biopharma Ltd., a specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in China, Australia, and Singapore. The company operates through Specialty Pharmaceutical and Nutraceutical segments. Its lead product candidate is Wafermine, a sublingual ketamine oral wafer for the treatment of acute mode..."
Retrieved from "https://stockhub.co/research/IX_Biopharma_Ltd."